Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02984228 · ClinicalTrials.gov registry record · Phase 4
Platelet-rich Plasma vs. Hyaluronic Acid for Glenohumeral Osteoarthritis
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT02984228: Completed Phase 4 study, sponsored by Hospital for Special Surgery, New York.
NCT02984228 is a Phase 4 study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 70 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02984228, a Phase 4 study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study seeks to expand the current literature in demonstrating potentially efficacious, conservative treatments in the management of glenohumeral osteoarthritis (OA) and will compare ultrasound-guided injections of hyaluronic acid vs. platelet-rich plasma. We aim to obtain information measuring potential benefits of these interventions and to observe for any adverse events.
Primary Outcome
Score ranges from 0-100, with a higher score representing higher disability.
Interventions
- DEVICE Ultrasound
- BIOLOGICAL PRP
- DRUG Hyaluronic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2014-12 |
| Est. Completion | 2020-11 |
| Phase | Phase 4 |
What the finished NCT02984228 record still lists
NCT02984228 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 3 interventions - of which Ultrasound is the first listed.
NCT02984228 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02984228 about?
NCT02984228 is a clinical study titled "Platelet-rich Plasma vs. Hyaluronic Acid for Glenohumeral Osteoarthritis". This study seeks to expand the current literature in demonstrating potentially efficacious, conservative treatments in the management of glenohumeral osteoarthritis (OA) and will compare ultrasound-guided injections of hyaluronic acid vs. platelet-rich plasma. We aim to obtain information measuring ...
What is the current status of trial NCT02984228?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2014-12. Estimated completion is 2020-11.
What interventions are being tested in trial NCT02984228?
The interventions under investigation include: Ultrasound (DEVICE), PRP (BIOLOGICAL), Hyaluronic Acid (DRUG).
Who is sponsoring clinical trial NCT02984228?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02984228's enrollment target sits among peer trials
70 1043rd of 2000 higher than 931 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia